Novel cardioprotective and regenerative therapies in acute myocardial infarction: a review of recent and ongoing clinical trials
Open Access Review by Nicholas Spath et al. (University of Edinburgh, UK) providing a synopsis of adjunctive cardioprotective and regenerative therapies currently undergoing or entering early clinical trials in the treatment of patients with acute myocardial infarction.
Following the original large-scale randomized trials of aspirin and β-blockade, there have been a number of major advances in pharmacological and mechanical treatments for acute myocardial infarction. However, myocardial infarction remains a major global cause of mortality and morbidity. In this Open Access Future Cardiology Review by Nicholas Spath et al. from the University of Edinburgh (UK) numerous proposed strategies for novel therapies currently in research development or undergoing clinical trials are discussed, in addition to considerations for future directions that should be explored.
Spath NB, Mills NL, Cruden NL. Novel cardioprotective and regenerative therapies in acutemyocardial infarction: a review of recent and ongoing clinical trials. Future Cardiol. 12(6), 655–672 (2016).
Author for correspondence: email@example.com